1. Home
  2. BBGI vs VTGN Comparison

BBGI vs VTGN Comparison

Compare BBGI & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beasley Broadcast Group Inc.

BBGI

Beasley Broadcast Group Inc.

HOLD

Current Price

$17.30

Market Cap

10.5M

ML Signal

HOLD

Logo VistaGen Therapeutics Inc.

VTGN

VistaGen Therapeutics Inc.

HOLD

Current Price

$0.25

Market Cap

10.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBGI
VTGN
Founded
1961
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.5M
10.8M
IPO Year
1999
2014

Fundamental Metrics

Financial Performance
Metric
BBGI
VTGN
Price
$17.30
$0.25
Analyst Decision
Hold
Analyst Count
0
3
Target Price
N/A
$0.90
AVG Volume (30 Days)
59.8K
569.7K
Earning Date
04-08-2026
06-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
48.01
N/A
Revenue
$232,179,463.00
N/A
Revenue This Year
N/A
$124.49
Revenue Next Year
N/A
$353.99
P/E Ratio
$0.33
N/A
Revenue Growth
69.89
N/A
52 Week Low
$3.14
$0.20
52 Week High
$29.30
$5.14

Technical Indicators

Market Signals
Indicator
BBGI
VTGN
Relative Strength Index (RSI) 31.89 46.52
Support Level $13.36 $0.23
Resistance Level $24.70 $0.32
Average True Range (ATR) 1.29 0.01
MACD -0.35 0.00
Stochastic Oscillator 8.78 49.49

Price Performance

Historical Comparison
BBGI
VTGN

About BBGI Beasley Broadcast Group Inc.

Beasley Broadcast Group Inc is a multi-platform media company, whose primary business is operating radio stations throughout the United States. The company offers local and national advertisers integrated marketing solutions across audio, digital and event platforms. It owns and operates stations in the following markets: Atlanta, GA, Augusta, GA, Boston, MA, Charlotte, NC, Detroit, MI, Fayetteville, NC, Fort Myers-Naples, FL, Las Vegas, NV, Middlesex, NJ, Monmouth, NJ, Morristown, NJ, Philadelphia, PA, Tampa-Saint Petersburg, FL, and Wilmington, DE. The company operates in two segments Audio and Digital.

About VTGN VistaGen Therapeutics Inc.

Vistagen Therapeutics Inc is a late clinical-stage therapeutics company focused on developing and commercializing medicines for patients with social anxiety disorder, depression, menopausal hot flashes, psychomotor impairment due to mental fatigue, and cancer cachexia. The company is engaged in developing intranasal product candidates called pherines, which leverage the understanding of nose-to-brain neurocircuitry. Vistagen's pherine pipeline consists of various product candidates like: Fasedienol, Itruvone, PH15, Refisolone, and PH284, which are being developed to provide treatment for a variety of disorders. Additionally, it is seeking potential partners for the further clinical development and commercialization of an oral drug candidate, AV-101, to treat certain neurological disorders.

Share on Social Networks: